Nanovi is a Danish medical device company that specializes in precision marking for improved cancer therapy. Their mission is to empower healthcare professionals by providing them with the best tools for image-guided high precision radiation therapy (IGRT) and surgery, ultimately benefiting cancer patients and healthcare efficiency. Nanovi offers a range of liquid fiducial markers, which are used to radiographically mark soft tissue in both humans and veterinary medicine.

Their flagship product, BioXmark, is a liquid fiducial marker designed for human use. It enhances target visibility on imaging, enabling high precision cancer radiation therapy, including proton beam therapy. By ensuring accurate target delineation and verification of patient setup during treatment, BioXmark supports superior treatment precision and quality.

Nanovi also offers PetXmark, a liquid fiducial marker specifically developed for use in dogs and cats. It has been clinically evaluated for the guidance of radiotherapy in skin and subcutaneous tumors in veterinary medicine, and is currently available in the US. Nanovi's products are derived from a patented biomaterial platform co-invented with the Department of Health Technology at the Technical University of Denmark, DTU.

Contact Nanovi for more information about their precision marking solutions and how they can benefit your medical practice